Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...

Prof James Catto from the University of Sheffield described the findings as a "major breakthrough" in treating bladder cancer ...

The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...

Bladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...

A specialist can diagnose bladder cancer using a variety of tests. “Bladder cancer can be diagnosed through a combination of ...

A “game-changer” study claims bladder cancer patients given an immunotherapy drug are a third less likely to see disease come back and are more likely to survive. Patients with advanced ...

They hope it will be approved by the Medicines and Healthcare Products Regulatory Agency to become the new standard of care.

Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice.

A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the ...